| NCT Number | NCT07638982 |
| Lead Sponsor | Northside Hospital, Inc. |
| Conditions | Diffuse Large B Cell Lymphoma (DLBCL), Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma (HGBCL), High-Grade B-Cell Lymphoma, Nos, PMBCL, Follicular Grade 3 Lymphoma |
| Enrollment | 29 participants |
| Start Date | 2026-10-31 |
| Primary Completion | 2028-12-31 (estimated) |
| Study Completion | 2029-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-10 |